Localization, substrate specificity, and drug resistance conferred by conjugate export pumps of the MRP family.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Advances in Enzyme Regulation

• Publication date

  2000-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0065-2571(99)00022-9PMID 10828358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ATP‐ and glutathione‐dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1

  1999cited by this paper
• Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane

  1999cited by this paper
• Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2.

  1999cited by this paper
• Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome.

  1999cited by this paper
• Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.

  1999cited by this paper
• Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2

  1999cited by this paper
• Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.

  1999cited by this paper
• MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs

  1999cited by this paper
• [Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome].

  1999cited by this paper
• MRP3, an organic anion transporter able to transport anti-cancer drugs.

  1999cited by this paper
• Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome.

  1999cited by this paper
• Human MRP3 transporter: identification of the 5'-flanking region, genomic organization and alternative splice variants.

  1999cited by this paper
• Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma.

  1999cited by this paper
• Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)*

  1999cited by this paper
• FROM VACUOLAR GS-X PUMPS TO MULTISPECIFIC ABC TRANSPORTERS.

  1998cited by this paper
• Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport.

  1998cited by this paper
• Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.

  1998cited by this paper
• Transport function and substrate specificity of multidrug resistance protein.

  1998cited by this paper
• Functional Analysis of a Canalicular Multispecific Organic Anion Transporter Cloned from Rat Liver*

  1998cited by this paper
• Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione.

  1998cited by this paper
• Mutations in the Canalicular Multispecific Organic Anion Transporter (cMOAT) Gene, a Novel ABC Transporter, in Patients with Hyperbilirubinemia II/Dubin-Johnson Syndrome

  1998cited by this paper
• Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.

  1998cited by this paper
• Multidrug resistance mediated by the ATP‐binding cassette transporter protein MRP

  1998cited by this paper
• Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF‐B

  1998cited by this paper
• Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome.

  1998cited by this paper
• The GS-X Pump in Plant, Yeast, and Animal Cells: Structure, Function, and Gene Expression

  1997cited by this paper
• Membrane Topology of the Multidrug Resistance Protein (MRP)

  1997cited by this paper
• Analysis of the intron-exon organization of the human multidrug-resistance protein gene (MRP) and alternative splicing of its mRNA.

  1997cited by this paper
• Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules.

  1997cited by this paper
• ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2.

  1997cited by this paper
• Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.

  1997cited by this paper
• Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAJ) gene in liver

  1997cited by this paper
• A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin‐Johnson syndrome

  1997cited by this paper
• ATP-dependent 17-Estradiol 17-(-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP)

  1996cited by this paper
• ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids.

  1996cited by this paper
• ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump.

  1996cited by this paper
• Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database.

  1996cited by this paper
• A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.

  1996cited by this paper
• Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome

  1996cited by this paper
• The canalicular conjugate export pump encoded by the cmrp/cmoat gene.

  1996cited by this paper
• cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats*

  1996cited by this paper
• Multidrug Resistance Protein (MRP)-mediated Transport of Leukotriene C and Chemotherapeutic Agents in Membrane Vesicles

  1996cited by this paper
• Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.

  1996cited by this paper
• Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump.

  1996cited by this paper
• Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport- deficient mutant hepatocytes

  1995cited by this paper
• Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

  1994cited by this paper
• The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates.

  1994cited by this paper
• ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.

  1994cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper

• The Multifaceted Role of Bilirubin in Liver Disease: A Literature Review

  2024cites this paper
• 7, 8-Dihydroxy-4-methyl coumarin alleviates cholestasis via activation of the Farnesoid X receptor in vitro and in vivo.

  2022cites this paper
• Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.

  2020cites this paper
• Targeting FXR in Cholestasis.

  2019cites this paper
• Substrate and method dependent inhibition of three ABC‐transporters (MDR1, BCRP, and MRP2)

  2017cites this paper
• Predicting liver toxicity on basis of transporter interaction profiles

  2016cites this paper
• Gene and protein expression in the oxaliplatin-resistant HT29/L-OHP human colon cancer cell line.

  2015cites this paper
• Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC/TERT1.

  2015cites this paper
• Role of nuclear factor-erythroid 2-related factor 2 (Nrf2) in the transcriptional regulation of brain ABC transporters during acute acetaminophen (APAP) intoxication in mice.

  2015cites this paper
• Evaluating the in vitro inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in predicting drug-induced hyperbilirubinemia.

  2013cites this paper
• N-Benzyloxycarbonyl-S-(2,4-dinitrophenyl)glutathione dibutyl diester is inhibitory to melarsoprol resistant cell lines overexpressing the T. bruceiMRPA transporter.

  2013cites this paper
• OATP1B1, OATP1B3, and OATP2B1

  2013cites this paper
• Multidrug resistance-associated protein 2 (MRP2/ABCC2)

  2013cites this paper
• Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P‐glycoprotein Inhibitor, in Healthy Male Participants

  2013cites this paper
• The Influence of Oral Antidiabetic Drugs on Cellular Drug Uptake Mediated by Hepatic OATP Family Members

  2013cites this paper
• Effect of Glucagon-Like Peptide 2 on Hepatic, Renal, and Intestinal Disposition of 1-Chloro-2,4-dinitrobenzene

  2012cites this paper
• An In Silico Classification Model for Putative ABCC2 Substrates

  2012cites this paper
• XENOSENSOR REGULATION OF ENZYMES AND TRANSPORTERS IN DRUG EXPOSURE AND DISEASE

  2011cites this paper
• Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs

  2011cites this paper
• Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects

  2010cites this paper
• Expression and localization of BCRP, MRP1 and MRP2 in intestines, liver and kidney in horse.

  2010cites this paper
• Saturation of Multidrug-Resistant Protein 2 (Mrp2/Abcc2)-Mediated Hepatobiliary Secretion: Nonlinear Pharmacokinetics of a Heterocyclic Compound in Rats after Intravenous Bolus Administration

  2009cites this paper
• Advancement of Structure-Activity Relationship of Multidrug Resistance-Associated Protein 2 Interactions

  2009cites this paper
• Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes.

  2009cites this paper
• Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis.

  2008cites this paper
• The influence of acetylcholinesterase reactivators on selected hepatic functions in rats.

  2008cites this paper
• Human ABC Transporters: Function, Expression, and Regulation

  2008cites this paper
• Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes.

  2008cites this paper
• Plasmodium falciparum multidrug resistance protein (MRP) gene expression under chloroquine and mefloquine challenge

  2008cites this paper
• Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis

  2008influential citation
• Cytochrome P450 3A and ABC-transport proteins in horse

  2008cites this paper
• Transporters and Drugs – An Overview

  2008cites this paper
• The Enzymatic Systems in the Formation and Transformation of Estrogens in Normal and Cancerous Human Breast: Control and Potential Clinical Applications

  2008cites this paper
• Structure-Activity Relationships for Interaction with Multidrug Resistance Protein 2 (ABCC2/MRP2): The Role of Torsion Angle for a Series of Biphenyl-Substituted Heterocycles

  2007cites this paper
• A physiological role for glucuronidated thyroid hormones: preferential uptake by H9c2(2-1) myotubes.

  2007cites this paper
• Efflux Transporter Expression and Acetaminophen Metabolite Excretion Are Altered in Rodent Models of Nonalcoholic Fatty Liver Disease

  2007cites this paper
• Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition

  2006cites this paper
• ABC transporters, neural stem cells and neurogenesis – a different perspective

  2006cites this paper
• HEPATIC AND EXTRAHEPATIC SYNTHESIS AND DISPOSITION OF DINITROPHENYL-S-GLUTATHIONE IN BILE DUCT-LIGATED RATS

  2006cites this paper
• Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.

  2006cites this paper
• Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway.

  2005cites this paper
• 5-FU uptake in peritoneal metastases after pretreatment with radioimmunotherapy or vasoconstriction: an autoradiographic study in the rat.

  2005cites this paper
• Transcriptional regulation of the rat Mrp3 gene promoter by the specificity protein (Sp) family members and CCAAT/enhancer binding proteins.

  2005cites this paper
• Combined effects of GSTP1 and MRP1 in melanoma drug resistance

  2005influential citation
• Alteration of the expression of adenosine triphosphate‐binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis

  2005cites this paper
• Estrogen Sulfotransferase in Breast Cancer

  2005cites this paper
• Gender‐specific expression of liver organic anion transporters in rat

  2005cites this paper
• A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy

  2004cites this paper
• Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects.

  2004influential citation
• Transport Characteristics of Fexofenadine in the Caco-2 Cell Model

  2004cites this paper
• Pharmacokinetic Analysis of Ramatroban Using a Recirculatory Model with Enterohepatic Circulation by Measuring Portal and Systemic Blood Concentration Difference in Sprague-Dawley and Eisai Hyperbilirubinemic Rats

  2004cites this paper
• Increased hepatic and renal expressions of multidrug resistance‐associated protein 3 in Eisai hyperbilirubinuria rats

  2004cites this paper
• Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study

  2004cites this paper
• Enterohepatic bile salt transporters in normal physiology and liver disease.

  2004cites this paper
• Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3).

  2004cites this paper
• Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics. iii: mechanisms for sinusoidal efflux of 4-methylumbelliferone sulfate

  2004cites this paper
• Modulation of organic anion transporting polypeptide 1 and multidrug resistance protein 3 expression in the liver and kidney of Gunn rats.

  2004cites this paper
• Transport of Bilirubin Conjugates across Hepatocellular Membrane Domains and the Conjugated Hyperbilirubinemia of Dubin-Johnson Syndrome

  2004cites this paper
• Drug Transporters and Their Role in Tissue Distribution

  2004cites this paper
• HK-2 CELLS AS A HUMAN MODEL OF GLUCURONIDE TRANSPORT

  2004cites this paper
• Molecular aspects of medicine: from experimental to clinical hepatology.

  2004cites this paper
• Drug transport proteins in the liver.

  2003cites this paper
• CHAPTER 20 – MRP2, THE APICAL EXPORT PUMP FOR ANIONIC CONJUGATES

  2003cites this paper
• Localization, Regulation, and Substrate Transport Properties of Bpt1p, a Saccharomyces cerevisiae MRP-Type ABC Transporter

  2002cites this paper
• Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine.

  2002cites this paper
• Multidrug resistance mediated by members of the MRP family

  2002cites this paper
• Multidrug Resistance–Associated Protein Family

  2002cites this paper
• Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei

  2002cites this paper
• A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies

  2002cites this paper
• Transport of leukotriene C4 and structurally related conjugates.

  2002cites this paper
• Expression and regulation of ABC transporter genes during liver regeneration

  2002cites this paper
• Sulfation through the looking glass—recent advances in sulfotransferase research for the curious

  2002cites this paper
• Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice.

  2002cites this paper
• ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

  2001cites this paper
• Sinusoidal Efflux of Taurocholate Is Enhanced in Mrp2-Deficient Rat Liver

  2001cites this paper
• Hepatic and Peritoneal Colorectal Metastases Aspects of Prognosis and Treatment

  2001cites this paper
• Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters.

  2001cites this paper
• Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia.

  2001cites this paper
• The interplay of glutathione-related processes in antioxidant defense.

  2001cites this paper
• Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance

  2000cites this paper
• Hepatic Secretion of Conjugated Drugs and Endogenous Substances

  2000cites this paper